Gene therapy trial for dry AMD halted early
NCT ID NCT03846193
First seen Feb 02, 2026 · Last updated Jun 18, 2026 · Updated 15 times
Summary
This study tested a single injection of GT005 gene therapy in 56 people with dry age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to check safety and whether it could slow disease progression. The trial was terminated early, so results are limited, but it aimed to control the disease rather than cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bristol Eye Hospital
Bristol, United Kingdom
-
Cincinnati Eye Institute
Cincinnati, Ohio, 45242, United States
-
Manchester Eye Hospital
Manchester, United Kingdom
-
Mid-Atlantic Retina
Philadelphia, Pennsylvania, 19107, United States
-
Midwest Eye Institute
Indianapolis, Indiana, 46290, United States
-
Moorfields Eye Hospital
London, United Kingdom
-
Ophthalamic Consultants of Boston (OCB)
Boston, Massachusetts, 02114, United States
-
Oxford University Hospital
Oxford, United Kingdom
-
Pepose Vision Institute
Chesterfield, Missouri, 63017, United States
-
Retina Clinic London
London, W1G 7LA, United Kingdom
-
Sierra Eye Associates
Reno, Nevada, 89502, United States
-
Sunderland Eye Infirmary
Sunderland, United Kingdom
-
Wolfe Eye Clinic
West Des Moines, Iowa, 50266, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.